This framework describes the building blocks and actions that ECDC will use to support and EU/EEA countries and the European Commission to achieve the Sustainable Development Goal (SDG).
Data are processed for the conduct of the carbapenem- and/or colistin-resistant Enterobacteriaceae (CCRE) survey as part of molecular surveillance of antimicrobial resistant pathogens according to a protocol. For the CCRE survey bacterial isolates (carbapenem and/or colistin-resistant Enterobacteriaceae and susceptible control isolates) and related patient data are collected in hospitals in 37 countries with the aim to determine transmission pathways and improve control measures.
This report presents the final conclusions from an evaluation of ECDC’s response to the 2009 influenza pandemic. The evaluation was undertaken by an external panel of experts with extensive experience in communicable disease control, crisis management, and influenza programmes. They considered ECDC’s performance in the areas of crisis management, surveillance, scientific advice and communication.
This document sets out the strategic priorities for all six ECDC disease-specific programmes from 2010 to 2013 based on a short description of the epidemiological background, the context in which ECDC works on that specific disease or disease group, and defined gaps that require action at the EU level.